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Abstract A group of novel human Ran-binding proteins,
RanBP3, was identified using the yeast two-hybrid system via
Ran-mediated interaction with the nucleotide exchange factor
RCC1. Several open reading frames, representing putative
alternatively spliced products, were established by cDNA
cloning. Two of them, RanBP3-a and RanBP3-b, encode nuclear
hydrophilic proteins of 499 and 562 amino acid residues. The
sequences contain FXFG motifs, characteristic of a subgroup of
nucleoporins, and a C-terminal domain showing similarity to the
Ran-binding protein RanBP1. These proteins are localized in the
nucleus, preferentially bind RanGTP and may be nuclear
effectors of the Ran pathway.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The small Ras-related GTPase Ran plays an essential role
in the transport of macromolecules beween the cytoplasm and
the nucleus (for a review see [1]). Ran is an abundant soluble
protein predominantly localized in the nucleus [2]. Its nucleo-
tide bound state is regulated by the Ran-speci¢c GTPase ac-
tivating protein RanGAP1 [3] and the speci¢c guanine nucleo-
tide exchange factor RCC1 [4]. RanGAP1 is cytoplasmic, or is
attached to the cytoplasmic margin of nuclear pore complexes
(NPC) after conjugation to a ubiquitin-like protein [5^7]. In
contrast, RCC1 is exclusively nuclear and bound to chromatin
[2,8]. The asymmetric subcellular distribution of both Ran
regulators is thought to result in a low concentration of
RanGTP in the cytoplasm vs. a high concentration of
RanGTP in the nucleus. This RanGTP gradient across the
nuclear pore complex is believed to be required for the for-
mation and dissociation of complexes involved in import and
export from the nucleus [9] (for a review see [10]).
There are two classes of RanGTP-binding proteins which
di¡er in function and in their binding sites on Ran. Members
of the importin L related class of transport factors are of
similar size (95^130 kDa) and have a weakly conserved con-
sensus sequence in their N-terminal regions involved in Ran
binding. Most of them were shown to bind RanGTP but not
RanGDP, and to inhibit both GTP hydrolysis and guanine
nucleotide exchange on Ran [11,12]. Within this class, import
factors like importin L/karyopherin L [13] and transportin
[14,15] bind RanGTP with distinctly higher a⁄nity than ex-
port factors like CAS [16], CRM1 [17^19], and exportin t/
Los1 [20]. The a⁄nity of the export factors for RanGTP is
considerably increased by cooperative binding of the cargo to
be exported.
Proteins of the second class bind to RanGTP at a di¡erent
site and inhibit nucleotide exchange but not hydrolysis [21,22].
They di¡er in size and share one or several regions of homol-
ogy to RanBP1. This small cytoplasmic protein acts as a dis-
sociation factor for the stable RanGTPWtransport factor com-
plex, thereby releasing the transport factor for a new round of
transport [16,23^27] and exposing RanGTP to nucleotide hy-
drolysis stimulated by RanGAP1 in the cytoplasm. A close
homologue of RanBP1, Yrb1p, has been identi¢ed in yeast as
an essential protein involved in chromosome stability and
nuclear protein import [28,29]. RanBP2, a protein of 358
kDa [30,31], is a vertebrate nucleoporin located at the short
¢bres on the cytoplasmic margin of the NPC. It contains four
RanBP1 homologous Ran-binding domains and numerous
FXFG motifs; the latter are typical for a subgroup of nucle-
oporins [32]. Yrb2p is a RanBP1-related protein from baker’s
yeast which is localized to the nucleus [33]. A yrb2 null-mu-
tant shows synthetic lethality with a mutation in the gene
rna1, encoding the RanGAP homologue [33]. Its ¢ssion yeast
homologue is the essential hba1p, which also resides in the
nucleus [34]. Here, we present human RanBP3-a and -b as
new members of this class of Ran-binding proteins.
2. Materials and methods
2.1. Strains and cDNA cloning
Plasmids were propagated in E. coli DH5K. Lambda libraries were
transfected into E. coli Y1090 hsdR. The E. coli strain BL21(DE3)-
pLysS [35] was used for expression of the 6UHis- or GST-fusion
proteins. Two human HeLa S3 5P-STRETCH cDNA libraries (Clon-
tech Laboratories GmbH, Heidelberg, Germany), cloned into Vgt11
and VDR2 vectors, respectively, were screened for full length RanBP3
cDNAs, using radiolabeled (DECAprimeII kit, Ambion, Austin, TX,
USA) RanBP3 DNA probes derived from RanBP3vN-217. Vgt11 in-
serts were PCR ampli¢ed using Vgt11 forward (5P-GGTGGCGAC-
GACTCCTGGAGCCCG) or reverse (5P-CAGACCAACTGG-
TAATGGTAGCGA) primers and subcloned into the pCRII vector
(Invitrogen BV, Leek, The Netherlands). Clones derived from the
VDR2 cDNA library were converted into plasmid pDR derivatives
by cre-lox mediated recombination in E. coli AM1 (Clontech). Several
cDNA clones were isolated, of which one with a cDNA insert of
3.2 kb contained the complete RanBP3-a open reading frame
(ORF) plus 1.5 kb of 3P-untranslated region (3P-UTR), a second
one with 1.8 kb the RanBP3-b ORF except for the ¢rst 8 nucleotides.
2.2. Two-hybrid screening
All components of the two-hybrid system were a generous gift from
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Dr. Stephen J. Elledge. The human peripheral lymphocyte VACT
cDNA library was converted into a plasmid cDNA (pACT) library
by in vivo recombination, and the transformation of yeast strains and
subsequent selection were done as described [26,36]. The cDNAs en-
coding human wild-type RCC1 and RCC1 alanine mutants [37],
kindly provided by Drs. Takeharu Nishimoto and Yoshiaki Azuma,
and the murine RanBP1/HTF9-A cDNA [22,38] were cloned into
pAS1-CYH2. Human Ran/TC4 cDNA [39] was cloned into pAS1-
CYH2 and pACT-II. Transformation of plasmids into yeast Y190
together with pAS1-CYH2-RCC1 or unrelated ‘bait’ constructs iden-
ti¢ed four positive clones, including RanBP3vN-217.
2.3. Plasmids for protein synthesis, production and puri¢cation of
recombinant proteins
The BamHI-XbaI DNA fragment of RanBP3-a was subcloned into
pBluescript II KS+ (Stratagene GmbH, Heidelberg, Germany) and
used for coupled in vitro transcription/translation experiments (TNT
T3 Coupled Wheat Germ Extract kit, Promega Corporation, Madi-
son, WI, USA). For synthesis of 6UHis-tagged RanBP3 polypeptides
in bacteria, cDNA fragments were cloned into the pET-14b vector
(AGS, Heidelberg, Germany). For bacterial synthesis of glutathione
S-transferase-(GST)-RanBP3-a, or for synthesis of RanBP3-a/
RanBP3-b in mammalian cell lines, PCR-ampli¢ed DNA was cloned
into the GST expression vector pGEX-4T-2 (Pharmacia Biotech Eu-
rope GmbH, Freiburg, Germany) or the expression vector pcDNA3
(Invitrogen), respectively. Gsp1p was a gift from Dr. Gabriel Schlen-
stedt. Bacterially synthesized human RCC1, Ran, RanQ69L and
Rna1p were puri¢ed as described [3,40]. 6UHis-tagged proteins
were produced in E. coli BL21. Cells were lysed by ultrasonication
in lysis bu¡er (20 mM HEPES, 0.5 mM DTT, 1 mM PMSF, pH 7.4
plus protease inhibitors Complete (Boehringer Mannheim)). The re-
combinant proteins were a⁄nity-puri¢ed on Ni-NTA silica resin (Qia-
gen) under non-denaturing conditions. The mass of recombinant
6UHis-RanBP3 was determined on a matrix-assisted laser desorption
ionization (MALDI) Re£ex II Mass Spectrometer (Bruker/Franzen).
2.4. Northern blot analysis
Total RNA and poly(A) RNA isolated from HeLa cells were
separated on agarose formaldehyde gels and transferred onto nitro-
cellulose. Human Multiple Tissue Northern (MTN) blots were from
Clontech. A DNA fragment from the coding region of RanBP3-a (nt
668^1305) was labeled by digoxigenin-11-dUTP (Boehringer Mann-
heim) incorporation by PCR. Human L-actin cDNA was labeled
with digoxigenin using the DECAprimeII kit (Ambion). Hybridiza-
tion conditions were as described [41]. Digoxigenin-labeled DNA was
detected by chemiluminescence (CDP-Star, Boehringer Mannheim).
2.5. Protein binding assays in vitro
GST-RanBP3-a (W25^50 Wg)-bound glutathione Sepharose beads
in bu¡er A (20 mM HEPES, 150 mM NaCl, 1 mM MgCl2, 0.5 mM
DTT, pH 7.4) were incubated for 30 min at 4‡C with 12 Wg of
RanGTP or RanGDP, or 20 Wg of RCC1 in a ¢nal volume of 70 Wl.
Alternatively, GST-RanBP3-a bound glutathione Sepharose beads
were incubated with 1 ml of HeLa soluble protein eluted from desalt-
ing columns (NAP5, Pharmacia, see below), with or without addition
of 60 Wg of RanQ69LGTP for 90 min at 4‡C. The mixtures were
centrifuged, the supernatant was recovered, beads were washed and
bound proteins were eluted twice with 10 mM glutathione in bu¡er A
in a ¢nal volume of 70 Wl. All samples were boiled in SDS sample
bu¡er. Labeling of Gsp1p and human Ran with [Q-32P]GTP and nu-
cleotide exchange assays was done as described [22].
2.6. Antibodies to RanBP3, immuno£uorescence studies
Rabbits were immunized with 6UHis-RanBP3-vN217 protein. In
addition, synthetic peptides derived from the sequences 20^32
(QKDKGQKSPAEQK-C) and 100^116 (SPEGGEDSDREDGNYC)
in RanBP3-a were coupled to Imject Maleimide Keyhole Limpet He-
mocyanin (Pierce, Rockford, IL, USA) and also used for immuniza-
tion of rabbits. Guinea pigs were immunized with peptide20^32-KLH.
The resulting antibodies were a⁄nity-puri¢ed either on 6UHis-
RanBP3-a protein that had been blotted onto nitrocellulose, or on
peptide20ÿ32 or peptide100ÿ116 that had been coupled to SulfoLink
coupling gel (Pierce). HeLa S3 and COS-7 cells were transfected
with plasmid DNA by electroporation [42]. Twenty-four hours after
transfection, cells were plated on coverslips and after 24 h of incuba-
tion were ¢xed in 2% formaldehyde in PBS at 25‡C and processed for
immuno£uorescence microscopy [26]. Secondary antibodies were £u-
orescein isothiocyanate (FITC)-labeled anti-rabbit or Texas Red-la-
beled anti-guinea pig IgG antibodies (Dianova GmbH, Hamburg,
Germany).
2.7. Immunoblotting and immunoprecipitation
Total protein extracts of mammalian cells were prepared, further
separated by SDS-PAGE, transferred onto nitrocellulose and immu-
nodetected as described [3]. For immunoprecipitation experiments,
107 cells were lysed for 30 min on ice in 1 ml low salt NP-40 bu¡er
(1% NP-40, 75 mM NaCl, 50 mM Tris-HCl, pH 8.0) containing
protease inhibitors. After centrifugation, 5 Wg of anti-RanBP3vN-
217 or 20 Wg of anti-peptide20ÿ32 antibodies (the latter with or without
20 Wg of synthetic peptide20ÿ32) were added to the supernatant and
incubated for 15 h at 4‡C. After addition of 20 Wl of protein A beads
(Boehringer Mannheim), incubations were continued for 3 h. Super-
natant was removed, the beads were washed, resuspended in 50 Wl of
SDS sample bu¡er and boiled for 5 min. Ten Wl of the samples were
analysed by SDS-PAGE and immunoblotting.
3. Results
3.1. RCC1 interacts with RanBP1-type Ran-binding proteins in
the yeast two-hybrid system
A plasmid encoding the nuclear guanine nucleotide ex-
change factor for Ran, pAS1-CYH2-RCC1, was transformed
into the yeast strain Y190 together with a pACT-human lym-
phocyte cDNA library and screened for transactivation of the
LacZ and HIS3 reporter genes. Four speci¢cally interacting
clones were isolated. Three of them contained cDNA frag-
ments coding for Ran-binding domains of RanBP2/Nup358
[30,31]. The fourth clone contained an insert of 2.7 kb with an
incomplete ORF of 345 codons, encoding the C-terminal re-
gion of a novel protein which we termed RanBP3 (Ran-bind-
ing protein 3), a 3P-untranslated region of 1.5 kb, and a pol-
y(A) sequence. To corroborate that the interaction of this
fragment RanBP3vN-217, which lacks the 217 amino-termi-
nal residues, with RCC1 is speci¢c, we also analyzed the in-
teraction of the full length RanBP3 (see below) with wild-type
RCC1 and with a series of RCC1 mutant proteins in the two-
hybrid assay. The full length RanBP3-a interacted with wild-
type RCC1 as bait, but did not interact with the RCC1 mu-
tant proteins D182A, H304A, and H410A. These mutants do
not interact with Ran in the two-hybrid screen and are unable
to complement tsBN2 cells containing a temperature sensitive
RCC1 allele, at the restrictive temperature [37]. The lack of
interaction in the two-hybrid assay was not due to instability
of the mutant RCC1 fusion proteins, since expression of the
hybrid proteins was detected in immunoblots (not shown). In
contrast, the RCC1 mutant R206A, which does complement
tsBN2 at high temperatures [37], interacted both with Ran
and RanBP3 in the two-hybrid system. These results showed
that binding of RanBP3 to RCC1 in the two-hybrid assay is
speci¢c and depends on the ability of RCC1 to interact with
its substrate Ran.
3.2. The ranbp3 gene is transcribed ubiquitously in human
tissues and codes for proteins that contain FXFG repeats
and a RanBP1 homology domain
To obtain cDNAs encoding full length RanBP3, human
lambda cDNA libraries were screened with DNA fragments
derived from RanBP3vN-217. We isolated one clone with a
3.2-kb insert including the entire ORF for RanBP3-a of
563 codons and a 3P-UTR of 1.5 kb that is terminated by a
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poly(A) sequence (Fig. 1A). An in-frame stop codon precedes
the ¢rst AUG codon that complies with the rule of Kozak for
translational initiation sites [43].
Three additional cDNA clones were isolated that show in-
sertions and deletions within the RanBP3-a ORF, £anked by
conserved residues of exon-exon boundaries [44] ; for example,
the coding region of one clone encoding RanBP3-b exhibited
a deletion of 68 codons and an insertion of 5 codons as com-
pared to RanBP3-a, resulting in the deduced amino acid se-
quence comprising 499 amino acid residues and corresponding
to a calculated mass of 53 476 Da. The 3P-UTR of this and
other clones is 1.2 kb shorter than that for RanBP3-a and
may therefore represent a smaller transcript resulting from
alternative polyadenylation.
Northern blot analysis on poly(A) RNA isolated from
HeLa cells (Fig. 1B) and 16 di¡erent human tissues (not
shown) using labeled RanBP3 cDNA fragments revealed tran-
scripts of approximately 1.8 and 3 kb in all samples, corre-
sponding in size to the isolated cDNA clones for RanBP3-a
and RanBP3-b. Therefore, the ranbp3 gene is ubiquitously
transcribed. The signal intensities were particularly strong in
testis and heart.
The deduced amino acid sequence of RanBP3-a consists of
562 residues with a calculated mass of 59 643 Da (Fig. 1C). It
contains a high percentage of charged residues with a calcu-
lated pI of 4.5. The protein is rich in serine/threonine residues
(16.9%) and the amino-terminal region is characterized by a
high content of proline residues. Two FXFG and two FXFX
type repeat motifs, previously described for a subclass of NPC
proteins [32], are present in the sequence. The C-terminal
region shows similarity to the Ran-binding domains of
RanBP1 homologues (Fig. 1D). The highest degree of se-
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Fig. 1. RanBP3 cDNA cloning, Northern blot analysis, and sequence. A: Schematic representation of cDNA clones. Top: cDNA insert
RanBP3vN-217 from the pACT clone isolated in the two-hybrid screen. Below: cDNA clones isolated from human lambda cDNA libraries.
The complete RanBP3-a ORF is shown as a closed box. Poly(A) sequences are represented by AAA. Putative exon insertions and deletions are
indicated: hatched triangle v68, deletion of a 204-bp DNA fragment in RanBP3-b, encoding amino acid residues 27^94 of RanBP3-a; black tri-
angle +5, insertion of 15 bp after codon 226 in RanBP3-b. B: Northern blot hybridization using digitonin-labeled DNA fragments from the
RanBP3 coding sequence to probe blots of isolated HeLa RNA. The same blot was stripped and re-hybridized with digitonin-labeled human L-
actin DNA (lower panel) to control RNA loading in each lane. Molecular size markers are indicated. C: Deduced amino acid sequence of
RanBP3-a. Synthetic peptides corresponding to the underlined sequence 20^32 and 101^116 were used to raise antibodies, the carboxy-terminal
region RanBP3vN-217 is indicated by an arrow. FXFG-type sequence motifs are shown by shaded boxes, the RanBP1-homologous sequence is
boxed. The sequence absent in RanBP3-b is underlined by a dashed line. A triangle denotes the position of a ¢ve residue (VCALE) insertion
after residue 226 in RanBP3-b. D: Sequence alignment of RanBP1 homologous domains. Conserved residues are indicated by black boxes. The
EMBL database entries are: human RanBP1 (X83617); human RanBP3a (this work, Y08697); S. cerevisiae yrb2 (Z38060); S. pombe
hba1(U38783); S. cerevisiae nup2 (X69964).
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quence identity (34%) within this region was found to the
RanBP1-related region of the ¢ssion yeast hba1p protein
[34]. The overall similarity between these proteins is 47%,
with 26% identical residues. The RanBP1 homology domain
of RanBP3-a/b also shows 32% sequence identity to the Ran-
binding domains of Yrb2p [33] and 20% to that of the nucle-
oporin Nup2p from baker’s yeast [45]. These proteins are
clearly divergent from other known RanBP1-homologous
proteins that exhibit sequence identities of 38^98% between
each other in the homologous regions.
3.3. RanBP3 proteins are synthesized in low amounts and occur
in the nucleus
In vitro transcription/translation of full length RanBP3-a
yielded one major translation product with an apparent mo-
lecular mass of 100 kDa as determined by SDS-PAGE, indi-
cating that the 5P-UTR confers successful translational initia-
tion (Fig. 2A). The bacterially synthesized 6UHis-RanBP3-a
showed the same mobility on SDS-PAGE, whereas 6UHis-
RanBP3-b migrated at a position corresponding to 80 kDa.
Mass spectrometric analysis of 6UHis-RanBP3-a revealed a
molecular mass of 62 kDa, in agreement with the calculated
mass of the 6UHis-tagged protein.
We raised rabbit polyclonal antibodies to the carboxy-ter-
minal region (RanBP3vN-217), and to synthetic peptides
(peptide20ÿ32 and peptide100ÿ116) deduced from the amino-ter-
minal region (Fig. 1C). All a⁄nity-puri¢ed RanBP3 antibod-
ies recognized the bacterially synthesized 6UHis-RanBP3-a in
immunoblots. Antibodies raised against peptide20ÿ32 recog-
nized RanBP3-b with reduced a⁄nity (Fig. 2B), since the
epitope recognized by peptide20ÿ32 antibodies is in part de-
leted in the smaller RanBP3-b protein (Fig. 1A and C).
Immunoprecipitation experiments using HeLa, BHK, and
COS-7 total cell lysates showed that a 100-kDa protein was
speci¢cally immunoprecipitated using the peptide20ÿ32 anti-
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Fig. 3. RanBP3 is localized to the nucleus. Top: Immuno£uores-
cence staining of HeLa cells using rabbit antibodies raised against
RanBP3vN-217. Center: Staining using rabbit peptide20ÿ32 antibod-
ies on African green monkey COS-7 cells transfected with an ex-
pression vector encoding RanBP3-b. Although the antibody also re-
acted with the monkey homologue of RanBP3, only transfected
cells containing increased amounts of human RanBP3 are seen due
to shortened ¢lm exposure. Bottom: Corresponding phase contrast
micrograph.
Fig. 2. RanBP3-a and -b encoded proteins. A: Coupled in vitro
transcription and translation of RanBP3-a. B: Proteins with appar-
ent molecular masses of 80 kDa and 100 kDa are immunoprecipi-
tated using rabbit anti-RanBP3 antibodies. Lanes 1^3, IP: proteins
immunoprecipitated from COS-7 cell total lysates. Rabbit RanBP3
antibodies raised against synthetic peptide20ÿ32 (lanes 1 and 2) pre-
cipitate a 100-kDa protein in the absence (3) but not in the pres-
ence (+) of synthetic peptide20ÿ32. Lane 3: rabbit RanBP3vN-217
antibodies precipitate proteins of 100 kDa and 80 kDa. The precipi-
tated proteins were immunodetected using guinea pig RanBP3 anti-
bodies. Lanes 4 and 5: immunodetection of overexpressed RanBP3
polypeptides using rabbit antibodies recognizing peptide100ÿ116 on
total protein extracts from COS-7 (lane 4) and HeLa (lane 5) cells
that had been transfected with expression vectors encoding RanBP3-
a (lane 4) and the splice variant RanBP3-b (lane 5).
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bodies, whereas the 80 kDa protein was not. Addition of the
synthetic peptide20ÿ32 abolished immunoprecipitation of the
100-kDa protein (Fig. 2B, lanes 1 and 2). In contrast, anti-
bodies raised against the C-terminal region of the RanBP3
proteins immunoprecipitated both a 100-kDa protein and sev-
eral polypeptides of approximately 80 kDa (Fig. 2B, lane 3).
A similar pattern of immunoreactive proteins was observed in
total protein extracts of mammalian cells that had been trans-
fected with RanBP3-a or RanBP3-b encoding expression vec-
tors (Fig. 2B, lanes 4 and 5). We could not detect immuno-
reactive bands on nitrocellulose blots using total lysate from
HeLa or COS-7 cells. Yet, separation of soluble cell protein
by ion exchange chromatography yielded fractions in which
two proteins of 80 and 100 kDa were immunolabeled (not
shown). Using bacterially synthesized puri¢ed RanBP3-b as
a reference for comparative immunoblotting, we estimated
that less than 1U105 molecules of the 80-kDa and 1U104
molecules of the 100-kDa protein are present per cell.
In indirect immuno£uorescence studies with di¡erent
RanBP3 antibodies HeLa, COS-7 and hamster BHK cells
gave a di¡use intranuclear staining that excluded nucleoli in
interphase cells. The top panel in Fig. 3 shows the staining of
HeLa cells with rabbit antiserum to RanBP3vN-217. The
same pattern was obtained with rabbit peptide20ÿ32 antibod-
ies. Likewise, overexpressed RanBP3-a (Fig. 3, center and
bottom), RanBP3-b or myc-epitope tagged RanBP3-b in
transfected COS-7 cells was exclusively located in the nucleus
and excluded from nucleoli. In mitosis, the antigen was dis-
persed throughout the cell and was not associated with chro-
matin (not shown).
3.4. RanBP3 proteins preferentially bind RanGTP and form a
Ran-dependent trimeric complex with RCC1 in vitro
To analyze the interactions of RanBP3-a and -b with Ran
and RCC1, the RanBP3 proteins were expressed as gluta-
thione S-transferase (GST) or 6UHis-tagged fusion proteins
and immobilized on glutathione Sepharose or NiNTA agarose
beads. In the example shown in Fig. 4A, GST-RanBP3-b or
GST beads were incubated with puri¢ed human RanGTP,
RanGDP and RCC1. Proteins bound to the beads were ana-
lyzed by SDS-PAGE. RanGTP, but not RanGDP binds to
GST-RanBP3-b (compare lanes 3 and 5). RCC1 alone does
not bind (Fig. 4B, lane 3). Yet in the presence of RCC1 and
RanGTP (Fig. 4B, lane 6) or RanGDP (not shown), a trimer-
ic complex of RanBP3-bWRanWRCC1 is formed. This complex,
similar to the RanBP1WRanWRCC1 complex [22], is likely to
exist in a nucleotide free state, as it is also formed in the
presence of EDTA. Ran or RCC1 alone or in combination
do not bind to immobilized GST.
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Fig. 5. RanBP3-a and -b proteins inhibit EDTA-induced guanine
nucleotide exchange on Ran. Yeast [Q-32P]GTP-Gsp1p (E) and hu-
man [Q-32P]GTP-Ran (O,a) were preincubated for 30 min with vari-
ous concentrations of RanBP3-a (E,O) or RanBP3-b (a). Protein-
bound radioactivity was determined 5 min after starting the ex-
change reaction by addition of EDTA and GDP.
Fig. 4. RanBP3-a speci¢cally binds human RanGTP and forms a
Ran-dependent complex with RCC1 in vitro. A: Immunoblot detec-
tion of Ran using rabbit anti-Ran antibodies. GST and GST-
RanBP3-a were immobilized on glutathione Sepharose beads and in-
cubated with puri¢ed human Ran and RCC1. Proteins bound to
the beads were eluted with glutathione. S, supernatant after incuba-
tion (lane 1); proteins eluted from beads (lanes 2^7). GST or GST-
RanBP3-a-bound beads were incubated with RanGTP (lanes 1^3),
RanGDP (lanes 4, 5) and RanGTP plus RCC1 (lanes 6, 7). B: Im-
munoblot detection of RCC1 using rabbit anti-RCC1 antibodies. S,
RCC1 in the supernatant (lanes 1, 4); proteins eluted from beads
(lanes 2, 3, 5, 6). Incubations were with RCC1 (lanes 1^3) and
RCC1 plus RanGTP (lanes 4^6). C: Binding of recombinant
RanQ69L (GTP-bound form), the RanGAP1-resistant mutant form
of Ran, from HeLa cell lysate to immobilized GST-RanBP3-b. Sam-
ples are: HeLa soluble lysate (lane 1), and proteins eluted from
beads with bu¡er containing 20 mM glutathione (lanes 2^7). About
5 Wg GST-RanBP3-b (lanes 2^4) or the importin L related GST-
RanBP5 [26] (lanes 5^7) were preincubated with 1-ml aliquots of
HeLa lysate (lanes 2 and 5), or with HeLa lysate containing 2.5 WM
of recombinant RanQ69L (lane 3, 4, 6, 7). Ran is immunodetected
using rabbit anti-Ran antibodies.
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Next, we analyzed whether RanBP3 could bind Ran in the
presence of HeLa lysates. Here, the majority of Ran is con-
verted to the GDP-bound form by the action of RanGAP1.
We therefore added GTP-bound RanQ69L, which is resistant
to RanGAP1 induced GTP hydrolysis, to HeLa lysate. The
¢nal concentration of RanQ69L in lysate aliquots was 2.5 WM,
about half of the endogenous Ran concentration. Under these
conditions, Ran was e⁄ciently bound to both GST-RanBP3-b
(Fig. 4C, lanes 3 and 4) and 6UHis-RanBP3-b beads (not
shown). Comparable amounts of RanQ69L were bound to
the importin L-related RanGTP-binding protein GST-
RanBP5 [26], that, with a binding constant of 3 nM, repre-
sents an import factor with high a⁄nity for RanGTP and was
used as a control in this experiment (lanes 6 and 7). Without
the addition of RanQ69L, a barely detectable amount of en-
dogenous Ran was bound to GST-RanBP3-b and GST-
RanBP5 (lane2 and 5), re£ecting the low concentration of
RanGTP in the lysate.
To estimate the a⁄nity of RanBP3 proteins for RanGTP,
we measured the ability of soluble RanBP3 proteins to inhibit
guanine nucleotide exchange on human RanGTP (Fig. 5), in
analogy to RanBP1 [22]. This exchange was induced by addi-
tion of EDTA which complexes Mg2 ions required for tight
nucleotide binding. High concentrations of RanBP3 proteins
were required to obtain inhibition, with apparent half maxi-
mal binding at 10 WM RanBP3-a, and even higher concentra-
tions for RanBP3-b, as compared to RanBP1 with half max-
imal inhibition at 0.1 nM [12]. Interestingly, the nucleoporin
Nup2p and the nuclear Ran-binding protein Yrb2p from
yeast also show binding constants in the lower WM range
(G. Schlenstedt and F.R.B., unpublished). Curiously, the
Ran homologue Gsp1p from baker’s yeast strongly binds to
RanBP3s, showing a half maximal inhibition of EDTA-in-
duced exchange at 40 nM with RanBP3-b (Fig. 5). Inhibition
of RCC1-induced nucleotide exchange is signi¢cant only at
unphysiologically high concentrations of RanBP3 (not
shown). Thus, stabilization of bound RanGTP against
RCC1-induced nucleotide exchange is probably not an in
vivo function of RanBP3. In analogy to RanBP1, stimulation
of RanGAP-induced GTPase activity on Ran was not inhib-
ited (not shown).
4. Discussion
We report here the identi¢cation of novel human Ran-bind-
ing proteins, RanBP3-a and -b, via interaction with RCC1 in
the yeast two-hybrid system. Ran-mediated interaction of
RCC1 in the two-hybrid system has been reported previously
for RanBP1 and RanBP2 [30,33]. In vitro, these proteins bind
to the nucleotide-free RCC1WRan complex, thereby blocking
RCC1-induced nucleotide exchange activity on Ran [22]. The
interaction of RanBP3 with RCC1 in the two-hybrid assay
most likely is also due to formation of a trimeric complex
involving the yeast Ran homologue Gsp1p, since in the two-
hybrid screen RanBP3 interacts speci¢cally with RCC1, but
not with a series of RCC1 mutants that have lost the ability to
interact with Ran. Furthermore, in in vitro binding assays
RanBP3 did not bind directly to RCC1, but a trimeric
RCC1WRanWRanBP3 complex was formed in the presence of
Ran. Yeast Gsp1p also shows high a⁄nity binding to RanBP3
(Fig. 5).
Evidence for the synthesis of di¡erent RanBP3 proteins in
mammalian cells comes from cDNA cloning, revealing the
presence of major alternatively spliced mRNAs, and from
the size of the encoded proteins corresponding to that of
cellular proteins detected by immunoprecipitation (Fig. 2B).
Immunolocalization showed that the RanBP3 proteins are
dispersed through the nucleoplasm. This resembles the loca-
tion of yeast Yrb2p (327 residues) in S. cerevisiae [33], and of
hba1p (399 residues) in ¢ssion yeast [34]. These two proteins
are smaller than RanBP3-a/b (562 and 499 residues) but are
grouped by sequence similarity with RanBP3 and Nup2p in a
distinct subfamily of the RanBP1-related proteins. They also
di¡er from the other RanBP1-type proteins by their nuclear or
nuclear pore complex associated location and by their rela-
tively low a⁄nity for RanGTP or the respective GTP-bound
Ran homologues ([34], F.R.B. and G. Schlenstedt, unpub-
lished results).
Yrb2p was found to interact with Gsp1pGTP in vitro and
in the two hybrid assay [33]. It is not essential for growth, but
a yrb2 null mutant shows synthetic lethality when combined
with a mutation in the yeast RanGAP1 homologue, rna1-1,
suggesting that both proteins share an essential function in the
regulation of the Ran GTPase pathway. Since deletion of the
yrb2 gene does not a¡ect import of NLS protein substrates or
mRNA export [46], Yrb2p is unlikely to participate in these
two transport pathways.
Instead, the low binding a⁄nities of this group of nuclear
RanBP1-related proteins may be a prerequisite for an intra-
nuclear function. In the absence of the exclusively cytoplasmic
RanGAP1, a high a⁄nity RanBPWRanGTP complex in the
nucleus probably would be unable to dissociate. Indeed, mi-
croinjection of RanBP1 into nuclei of Xenopus oocytes leads
to a block in transport through NPCs [9]. A high concentra-
tion of RanGTP in the nucleus (s 10 WM) ensures that com-
plexes with low a⁄nity nuclear Ran-binding proteins can be
formed and dissociated reversibly. Analysis of interacting pro-
teins and of RanBP3 mutants will help to determine the cel-
lular function for this new group of nuclear RanBP1 related
proteins.
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